Hypertrophic cardiomyopathy in the elderly

Geriatrics and Gerontology International

Volumn 10, Issue 1, 2010, Pages 9-16

  Kubo, Toru ^a   Kitaoka, Hiroaki ^a   Okawa, Makoto ^a   Nishinaga, Masanori ^a   Doi, Yoshinori L ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Atrial fibrillation; Embolism; Heart failure; Hypertrophic cardiomyopathy; Lifelong emodeling

Indexed keywords

ALPHA TROPOMYOSIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN 2; TROPONIN I; TROPONIN T;

AGE DISTRIBUTION; CLINICAL FEATURE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR GENETICS; MORPHOLOGY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYSTOLIC DYSFUNCTION;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; JAPAN; MALE; PREVALENCE; REGISTRIES; VENTRICULAR REMODELING;

EID: 73049098538     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2009.00572.x     Document Type: Review

References (36)

1. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785.
2. Maron BJ, McKenna WJ, Danielson GK. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
3. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
4. Niimura H, Bachinski LL, Sangwatanaroj S. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998, 338:1248-1257.
5. Maron BJ, Niiura H, Casey SA. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001, 38:315-321.
6. McKenna WJ, Deanfield JE, Faruqui A, England D, Oakley MC, Goodwin JF. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981, 47:532-538.
7. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981, 48:252-257.
8. Seiler C, Hess OM, Schoenbeck M. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 1991, 17:634-642.
9. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 1995, 26:1529-1536.
10. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999, 281:650-655.
11. Kofflard MJM, Ten Cate FJ, van der Lee C, van Domberg RT. Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003, 41:987-993.
12. Maron BJ, Olivotto I, Spirito P. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000, 102:858-864.
13. Kubo T, Kitaoka H, Okawa M. Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy: results from Kochi RYOMA study. Circ J 2009, 73:1599-1605.
14. Bonne G, Carrier L, Richard P, Hainque B, Scwwartz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res 1998, 83:580-593.
15. Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 2005, 6:185-216.
16. Niimura H, Patton KK, McKenna WJ. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002, 105:446-451.
17. Anan R, Niimura H, Takenaka T, Hamasaki S, Tei C. Mutations in the genes for sarcomeric proteins in Japanese patients with onset sporadic hypertrophic cardiomyopathy after age 40 years. Am J Cardiol 2007, 99:1750-1754.
18. Van Driest SL, Jaeger MA, Ommen SR. Comprehensive analysis of beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:602-610.
19. Van Driest SL, Vasile VC, Ommen SR. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 44:1903-1910.
20. Maron BJ, Casey SA, Hauser RG, Appli DM. Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol 2003, 42:882-888.
21. Shapiro LM. Hypertrophic cardiomyopathy in the elderly. Br Heart J 1990, 63:265-266.
22. Lever HM, Karam RF, Currie P, Healy BP. Hypertrophic cardiomyopathy in the elderly: dintinctions from the young based on cardiac shape. Circulation 1989, 79:580-589.
23. Lewis JF, Maron BJ. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 1989, 13:36-45.
24. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am J Cardiol 1994, 73:1105-1111.
25. Hirota T, Kitaoka H, Kubo T, Okawa M, Furuno T, Doi YL. Morphologic characteristics of hypertrophic cardiomyopathy of the elderly with cardiac myosin-binding protein C gene mutations. Circ J 2006, 70:875-879.
26. Binder J, Ommen SR, Gersh BJ. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 2006, 81:459-467.
27. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998, 81:1339-1344.
28. Kubo T, Kitaoka H, Okawa M. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein C gene among Japanese. J Am Coll Cardiol 2005, 46:1737-1743.
29. Kokado H, Shimizu M, Yoshio H. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 2000, 102:663-669.
30. Kimura A. Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J 2008, 72(A):A38-A48. Suppl
31. Elliott PM, Poloniecki J, Dickie S. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000, 36:2212-2218.
32. Kitaoka H, Kubo T, Okawa M, Hitomi N, Furuno T, Doi YL. Left ventricular remodeling of hypertrophic cardiomyopathy: longitudinal observation in a rural community. Circ J 2006, 70:1543-1549.
33. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999, 281:650-655.
34. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001, 104:2517-2524.
35. Maron BJ, Olivotto I, Bellone P. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 39:301-307.
36. Nagai T, Ogimoto A, Okayama H. A985G polymorphism of the endothelin-2 gene and atrial fibrillation in patients with hypertrophic cardiomyopathy. Circ J 2007, 71:1932-1936.